Literature DB >> 20702793

Is the lithium-for-ALS genie back in the bottle?: Not quite.

Carmel Armon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702793     DOI: 10.1212/WNL.0b013e3181ed9ef7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm.

Authors:  Paul Wicks; Timothy E Vaughan; Michael P Massagli; James Heywood
Journal:  Nat Biotechnol       Date:  2011-04-24       Impact factor: 54.908

2.  Patient, study thyself.

Authors:  Paul Wicks
Journal:  BMC Med       Date:  2018-11-23       Impact factor: 8.775

3.  Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  K E Morrison; S Dhariwal; R Hornabrook; L Savage; D J Burn; T K Khoo; J Kelly; C L Murphy; A Al-Chalabi; A Dougherty; P N Leigh; L Wijesekera; M Thornhill; C M Ellis; K O'Hanlon; J Panicker; L Pate; P Ray; L Wyatt; C A Young; L Copeland; J Ealing; H Hamdalla; I Leroi; C Murphy; F O'Keeffe; E Oughton; L Partington; P Paterson; D Rog; A Sathish; D Sexton; J Smith; H Vanek; S Dodds; T L Williams; I N Steen; J Clarke; C Eziefula; R Howard; R Orrell; K Sidle; R Sylvester; W Barrett; C Merritt; K Talbot; M R Turner; C Whatley; C Williams; J Williams; C Cosby; C O Hanemann; I Iman; C Philips; L Timings; S E Crawford; C Hewamadduma; R Hibberd; H Hollinger; C McDermott; G Mils; M Rafiq; P J Shaw; A Taylor; E Waines; T Walsh; R Addison-Jones; J Birt; M Hare; T Majid
Journal:  Lancet Neurol       Date:  2013-02-27       Impact factor: 44.182

Review 4.  Subjects no more: what happens when trial participants realize they hold the power?

Authors:  Paul Wicks; Timothy Vaughan; James Heywood
Journal:  BMJ       Date:  2014-01-28

5.  Could digital patient communities be the launch pad for patient-centric trial design?

Authors:  Paul Wicks
Journal:  Trials       Date:  2014-05-15       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.